Showing results (481-490 of 491) with videos related to
Sort By:
Pageof 50
Clinical and Translational Radiation Oncology|December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancerDavid J Thomson, Clare Cruickshank, Helen Baines, et al.Nature Biotechnology|July 22, 2008
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexJagath R Junutula, Helga Raab, Suzanna Clark, et al.Inflammatory Bowel Diseases|October 10, 2017
Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort StudyJacqueline So, Whitney Tang, Wai Keung Leung, et al.Nature Biotechnology|January 24, 2012
Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugatesBen-Quan Shen, Keyang Xu, Luna Liu, et al.Journal of Neuro-Oncology|April 11, 2026
Neurobehavioral outcomes and associated risk factors in pediatric brain tumor survivorsYuliang Wang, Wing Lam Chan, Fei Li, et al.Blood Cancer Discovery|August 12, 2022
Pharmacogenomic Profiling of Pediatric Acute Myeloid Leukemia to Identify Therapeutic Vulnerabilities and Inform Functional Precision MedicineHan Wang, Kathy Yuen Yee Chan, Chi Keung Cheng, et al.JACC. Asia|April 15, 2026
Asian Pacific Society of Cardiology Consensus Statements on the Use of Transcatheter Edge-to-Edge Repair in the Treatment of Tricuspid and Mitral RegurgitationKhung Keong Yeo, David W M Muller, Jian'an Wang, et al.Frontiers in Immunology|July 28, 2017
Family History of Early Infant Death Correlates with Earlier Age at Diagnosis But Not Shorter Time to Diagnosis for Severe Combined ImmunodeficiencyAnderson Dik Wai Luk, Pamela P Lee, Huawei Mao, et al.European Journal of Heart Failure|May 11, 2024
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialScott D Solomon, John W Ostrominski, Muthiah Vaduganathan, et al.The New England Journal of Medicine|September 3, 2024
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Muthiah Vaduganathan, et al.Pageof 50